In the last trading session, 1.51 million Kairos Pharma Ltd (AMEX:KAPA) shares changed hands as the company’s beta touched 0. With the company’s per share price at $0.71 changed hands at $0.04 or 5.98% during last session, the market valuation stood at $11.95M. KAPA’s last price was a discount, traded about -463.38% off its 52-week high of $4.00. The share price had its 52-week low at $0.40, which suggests the last value was 43.66% up since then. When we look at Kairos Pharma Ltd’s average trading volume, we note the 10-day average is 0.92 million shares, with the 3-month average coming to 802.41K.

Kairos Pharma Ltd (AMEX:KAPA) trade information

Instantly KAPA was in green as seen at the end of in last trading. With action 10.78%, the performance over the past five days has been green. However, in the 30-day time frame, Kairos Pharma Ltd (AMEX:KAPA) is 28.42% up. Looking at the short shares, we see there were 0.19 million shares sold at short interest cover period of 0.12 days.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -23.37%. The 2025 estimates are for Kairos Pharma Ltd earnings to increase by 7.25%, but the outlook for the next 5-year period is at -24.45% per year.

KAPA Dividends

Kairos Pharma Ltd is expected to release its next quarterly earnings report on 2025-May-14.

Kairos Pharma Ltd (AMEX:KAPA)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 47.25% of Kairos Pharma Ltd shares while 9.36% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 17.75%.